165 related articles for article (PubMed ID: 38218945)
1. Loss of RND3/RHOE controls entosis through LAMP1 expression in hepatocellular carcinoma.
Basbous S; Dif L; Dantzer C; Di-Tommaso S; Dupuy JW; Bioulac-Sage P; Raymond AA; Desdouets C; Saltel F; Moreau V
Cell Death Dis; 2024 Jan; 15(1):46. PubMed ID: 38218945
[TBL] [Abstract][Full Text] [Related]
2. Silencing of RND3/RHOE inhibits the growth of human hepatocellular carcinoma and is associated with reversible senescence.
Basbous S; Paysan L; Sena S; Allain N; Hiriart JB; Dugot-Senant N; Rousseau B; Chevret E; Lagrée V; Moreau V
Cancer Gene Ther; 2022 May; 29(5):437-444. PubMed ID: 35256752
[TBL] [Abstract][Full Text] [Related]
3. Rnd3/RhoE Is down-regulated in hepatocellular carcinoma and controls cellular invasion.
Grise F; Sena S; Bidaud-Meynard A; Baud J; Hiriart JB; Makki K; Dugot-Senant N; Staedel C; Bioulac-Sage P; Zucman-Rossi J; Rosenbaum J; Moreau V
Hepatology; 2012 Jun; 55(6):1766-75. PubMed ID: 22234932
[TBL] [Abstract][Full Text] [Related]
4. RhoE is frequently down-regulated in hepatocellular carcinoma (HCC) and suppresses HCC invasion through antagonizing the Rho/Rho-kinase/myosin phosphatase target pathway.
Ma W; Wong CC; Tung EK; Wong CM; Ng IO
Hepatology; 2013 Jan; 57(1):152-61. PubMed ID: 22829315
[TBL] [Abstract][Full Text] [Related]
5. Induction of entosis by epithelial cadherin expression.
Sun Q; Cibas ES; Huang H; Hodgson L; Overholtzer M
Cell Res; 2014 Nov; 24(11):1288-98. PubMed ID: 25342558
[TBL] [Abstract][Full Text] [Related]
6. Fate of Entosis: From the Beginning to the End in Untreated Advanced Breast Cancer.
Dziuba I; Gawel AM; Tyrna P; Rybczynska J; Bialy LP; Mlynarczuk-Bialy I
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569518
[TBL] [Abstract][Full Text] [Related]
7. RhoE stimulates neurite-like outgrowth in PC12 cells through inhibition of the RhoA/ROCK-I signalling.
Talens-Visconti R; Peris B; Guerri C; Guasch RM
J Neurochem; 2010 Feb; 112(4):1074-87. PubMed ID: 19968760
[TBL] [Abstract][Full Text] [Related]
8. RhoE/ROCK2 regulates chemoresistance through NF-κB/IL-6/ STAT3 signaling in hepatocellular carcinoma.
Ma W; Sze KM; Chan LK; Lee JM; Wei LL; Wong CM; Lee TK; Wong CC; Ng IO
Oncotarget; 2016 Jul; 7(27):41445-41459. PubMed ID: 27213590
[TBL] [Abstract][Full Text] [Related]
9. Rnd3/RhoE induces tight junction formation in mammary epithelial tumor cells.
Rubenstein NM; Chan JF; Kim JY; Hansen SH; Firestone GL
Exp Cell Res; 2005 Apr; 305(1):74-82. PubMed ID: 15777789
[TBL] [Abstract][Full Text] [Related]
10. p53-dependent elimination of aneuploid mitotic offspring by entosis.
Liang J; Niu Z; Zhang B; Yu X; Zheng Y; Wang C; Ren H; Wang M; Ruan B; Qin H; Zhang X; Gu S; Sai X; Tai Y; Gao L; Ma L; Chen Z; Huang H; Wang X; Sun Q
Cell Death Differ; 2021 Feb; 28(2):799-813. PubMed ID: 33110215
[TBL] [Abstract][Full Text] [Related]
11. Homotypic Entosis as a Potential Novel Diagnostic Marker in Breast Cancer.
Dziuba I; Gawel AM; Tyrna P; Machtyl J; Olszanecka M; Pawlik A; Wójcik C; Bialy LP; Mlynarczuk-Bialy I
Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047791
[TBL] [Abstract][Full Text] [Related]
12. Entosis: Cell-in-Cell Formation that Kills Through Entotic Cell Death.
Florey O; Kim SE; Overholtzer M
Curr Mol Med; 2015; 15(9):861-6. PubMed ID: 26511711
[TBL] [Abstract][Full Text] [Related]
13. Consecutive entosis stages in human substrate-dependent cultured cells.
Garanina AS; Kisurina-Evgenieva OP; Erokhina MV; Smirnova EA; Factor VM; Onishchenko GE
Sci Rep; 2017 Oct; 7(1):12555. PubMed ID: 28970591
[TBL] [Abstract][Full Text] [Related]
14. Entosis: From Cell Biology to Clinical Cancer Pathology.
Mlynarczuk-Bialy I; Dziuba I; Sarnecka A; Platos E; Kowalczyk M; Pels KK; Wilczynski GM; Wojcik C; Bialy LP
Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32883000
[TBL] [Abstract][Full Text] [Related]
15. The RhoA GEF Syx is a target of Rnd3 and regulated via a Raf1-like ubiquitin-related domain.
Goh LL; Manser E
PLoS One; 2010 Aug; 5(8):e12409. PubMed ID: 20811643
[TBL] [Abstract][Full Text] [Related]
16. Regulation of myosin activation during cell-cell contact formation by Par3-Lgl antagonism: entosis without matrix detachment.
Wan Q; Liu J; Zheng Z; Zhu H; Chu X; Dong Z; Huang S; Du Q
Mol Biol Cell; 2012 Jun; 23(11):2076-91. PubMed ID: 22496418
[TBL] [Abstract][Full Text] [Related]
17. Orai1 is an Entotic Ca
Lee AR; Park CY
Adv Sci (Weinh); 2023 May; 10(14):e2205913. PubMed ID: 36960682
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiological Functions of Rnd3/RhoE.
Jie W; Andrade KC; Lin X; Yang X; Yue X; Chang J
Compr Physiol; 2015 Dec; 6(1):169-86. PubMed ID: 26756630
[TBL] [Abstract][Full Text] [Related]
19. G-protein-coupled receptor signaling and polarized actin dynamics drive cell-in-cell invasion.
Purvanov V; Holst M; Khan J; Baarlink C; Grosse R
Elife; 2014 Jun; 3():. PubMed ID: 24950964
[TBL] [Abstract][Full Text] [Related]
20. Rnd3 in Cancer: A Review of the Evidence for Tumor Promoter or Suppressor.
Paysan L; Piquet L; Saltel F; Moreau V
Mol Cancer Res; 2016 Nov; 14(11):1033-1044. PubMed ID: 27555595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
